Market Overview:
The global hepatitis C virus (HCV) market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of HCV, rising demand for better treatment options, and growing awareness about HCV. The hepatitis C virus (HCV) therapeutics segment is expected to dominate the global HCV market during the forecast period. This can be attributed to the increasing number of new drug approvals for treating HCV and rising demand for better treatment options. The vaccine segment is projected to grow at a high rate during the forecast period owing to initiatives taken by various governments and organizations worldwide for vaccination against HCV infection. In terms of application, hospitals are expected to account for the largest share of the global hepatitis C virus (HCV) market during 2018-2030 owingtothe large patient population base.
 Industry Outlook.svg)
Product Definition:
Hepatitis C virus (HCV) is a virus that causes hepatitis, an inflammation of the liver. HCV is a leading cause of chronic liver disease and is responsible for up to 80% of all cases of cirrhosis in the United States.
Therapeutics:
Therapeutics is the branch of medicine that deals with diseases caused by viruses, bacteria, fungus or parasites. The HCV market is expected to witness significant growth over the forecast period owing to increasing prevalence of hepatitis globally and high treatment cost in developed countries.
According to WHO statistics published in 2015 around 130 million people were suffering from chronic hepatitis globally which increases the demand for therapeutics agents significantly.
Vaccine:
A vaccine is a medical product primarily designed to stimulate an immune response in the body against a particular disease. The term vaccine often refers to immunization against the virus that causes that disease. In this case, it refers to immunization against Hepatitis C Virus (HCV).
Application Insights:
Based on the application, the global hepatitis C virus (HCV) market is segmented into hospitals, ambulatory surgical centers, and diagnostic centers. Hospitals held the largest share in 2017 owing to factors such as a large patient base and prevalence of HCV infection in hospitals. In addition, an increase in healthcare spending along with government initiatives to reduce hospital-acquired infections is anticipated to drive growth over the forecast period.
Ambulatory surgical center (ASC) are projected to grow at a faster rate than that of hospitals during the forecast period due largely to increasing awareness about preventable diseases among ASC providers coupled with patients traveling from remote areas for medical care at these facilities. Furthermore, growing investments by governments across various regions towards development of advanced diagnostics and therapeutics infrastructure are expected fuel demand over next seven years.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing awareness levels are some of the factors responsible for its growth. In addition, growing prevalence of chronic diseases such as diabetes is expected to increase the demand for advanced therapeutics in this region. For instance, according to a study published by CDC National Center for Health Statistics (NCHS), from 2015 to 2016 around 29 million people were living with diabetes in U.S.
Asia Pacific HCV market was valued at USD X million in 2017.
Growth Factors:
- Increasing incidence of HCV infection: The global incidence of HCV infection is increasing at a rapid pace. This is primarily attributed to the growing population of high-risk groups, such as intravenous drug users and people who have received blood transfusions before 1992.
- Emergence of new therapies: The development of novel therapies for the treatment of HCV has revolutionized the management landscape for this disease. These therapies are highly efficacious and offer a better prognosis to patients than older treatments options.
- Growing awareness about HCV: There is a growing awareness among people about the risks associated with HCV infection and its potential consequences on health outcomes. This has led to an increase in demand for diagnosis and treatment services for this condition worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hepatitis C Virus (HCV) Market Research Report
By Type
Therapeutics, Vaccine
By Application
Hospitals, Ambulatory Surgical Centers, Diagnostic Centers
By Companies
Merck, Genentech, Vertex, Janssen and Medivir, F. Hoffmann-La Roche, Bristol Myers Squibb, AbbVie, Gilead Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Hepatitis C Virus (HCV) Market Report Segments:
The global Hepatitis C Virus (HCV) market is segmented on the basis of:
Types
Therapeutics, Vaccine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Diagnostic Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Genentech
- Vertex
- Janssen and Medivir
- F. Hoffmann-La Roche
- Bristol Myers Squibb
- AbbVie
- Gilead Sciences
 Market Overview.svg)
Highlights of The Hepatitis C Virus (HCV) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Therapeutics
- Vaccine
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hepatitis C Virus (HCV) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HCV is a virus that attacks the liver. It can cause serious health problems, including cirrhosis (a scarring of the liver) and death. HCV is spread through contact with blood, semen, or other body fluids from an infected person. It can also be spread through sharing needles used to inject drugs using shared equipment (such as drug use sites). HCV is most commonly found in people who are HIV positive or who have had close contact with someone who is HIV positive.
Some of the major companies in the hepatitis c virus (hcv) market are Merck, Genentech, Vertex, Janssen and Medivir, F. Hoffmann-La Roche, Bristol Myers Squibb, AbbVie, Gilead Sciences.
The hepatitis c virus (hcv) market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hepatitis C Virus (HCV) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hepatitis C Virus (HCV) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hepatitis C Virus (HCV) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hepatitis C Virus (HCV) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hepatitis C Virus (HCV) Market Size & Forecast, 2020-2028
4.5.1 Hepatitis C Virus (HCV) Market Size and Y-o-Y Growth
4.5.2 Hepatitis C Virus (HCV) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Therapeutics
5.2.2 Vaccine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Diagnostic Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hepatitis C Virus (HCV) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hepatitis C Virus (HCV) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Therapeutics
9.6.2 Vaccine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Diagnostic Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Therapeutics
10.6.2 Vaccine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Diagnostic Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Therapeutics
11.6.2 Vaccine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Diagnostic Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Therapeutics
12.6.2 Vaccine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Diagnostic Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Therapeutics
13.6.2 Vaccine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Diagnostic Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hepatitis C Virus (HCV) Market: Competitive Dashboard
14.2 Global Hepatitis C Virus (HCV) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Genentech
14.3.3 Vertex
14.3.4 Janssen and Medivir
14.3.5 F. Hoffmann-La Roche
14.3.6 Bristol Myers Squibb
14.3.7 AbbVie
14.3.8 Gilead Sciences
